Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sanak, L. Mastalerz, A. Gielicz, B. Sokolowska, N. Celejewska-Wójcik, A. Szczeklik (Kracow, Poland). Targeted eicosanoid lipidomics of induced sputum as compared to exhaled breath condensate in asthmatics. Eur Respir J 2011; 38: Suppl. 55, 4789

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory mediators in exhaled breath condensate, induced sputum and saliva Source: Eur Respir J 2004; 24: Suppl. 48, 678s Year: 2004 Validation of eicosanoid measurements in exhaled breath condensate Source: Eur Respir J 2002; 20: Suppl. 38, 422s Year: 2002 Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004 Content of nitric oxide in the exhaled breath condensate, induced sputum and BAL in asthma and COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 369s Year: 2006 Ozone-induced airway inflammation and its attenuation by corticosteroids are detectable in sputum samples but not in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 577s Year: 2004 Cytokines in exhaled breath condensate of patients with asthma Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma Source: Eur Respir J 2002; 20: 1393-1398 Year: 2002 Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 Metabolomics applied to exhaled breath condensate in asthmatic children treated with inhaled steroids Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Cysteinyl leukotrienes in urine and exhaled breath condensate in asthmatics and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Endogenous and exogenous metabolites in exhaled breath condensate in asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exercise-induced changes in concentrations of cysteinyl-leukotrienes in exhaled breath condensate Source: Eur Respir J 2004; 24: Suppl. 48, 680s Year: 2004 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 Nasal lavage cysteinyl-leukotrienes correlate with exhaled breath condensate in children Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006 Correlation of LTB4 with α-amylase in exhaled breath condensate Source: Eur Respir J 2005; 26: Suppl. 49, 372s Year: 2005 Leukotrienes in exhaled breath condensate of children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002